Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Diagnostic implications of telomerase activity in pleural effusions

E. Garcia-Pachon, I. Padilla-Navas
European Respiratory Journal 2004 23: 653-654; DOI: 10.1183/09031936.04.00123204
E. Garcia-Pachon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. Padilla-Navas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editor:

In a recent issue of the European Respiratory Journal, Dikmen et al. 1 analysed the diagnostic efficacy of telomerase activity in pleural fluid for distinguishing between benign and malignant effusions. They found that the sensitivity and specificity of telomerase activity for diagnosing malignancy was 82 and 80%, respectively. With these data the authors concluded that telomerase activity is a highly sensitive diagnostic biomarker for malignancy and may be used as an adjunct to cytological findings in determining malignant pleural effusions. However, in our opinion, this affirmation can not be applied to clinical practice.

Sensitivity and specificity are important points in the study of the diagnostic value of a test. However, from a clinical point of view, other measures of diagnostic accuracy are of great interest 2, i.e. likelihood ratios and predictive values. Likelihood ratios are the likelihood that a given test result would be expected in a patient with the target disorder compared to the likelihood that the same result would be expected in a patient without the target disorder, and predictive values are the post-test probability 3, 4. We calculated these measures using the data reported by Dikmen et al. 1, and obtained positive and negative likelihood ratios of 4.1 and 0.22, respectively, which are of modest diagnostic interest 3, 4. The positive predictive value, in this case, represents the probability that a patient has a malignant pleural effusion if telomerase activity is detected in the pleural fluid. Although it obviously depends on pre-test probability, this predictive value is very low, especially when the prevalence (pre-test probability) is ∼20–30%, as is usually observed in general hospitals (table 1⇓) 5. These findings are similar to those obtained when using classical tumour markers 5.

View this table:
  • View inline
  • View popup
Table 1—

Probability (positive predictive value) of malignant pleural effusion when telomerase activity is detected in pleural fluid

In our experience 6, the determination of C‐reactive protein (CRP) in pleural exudates, which is an inexpensive test and easy to perform, would be of greater interest. A low CRP level (<20 mg·L−1) has a better positive likelihood ratio and positive predictive value for diagnosing malignancy than those of telomerase activity, with the additional advantage that a level >45 mg·L−1 virtually rules out this possibility.

In conclusion, we consider that the measurement of telomerase activity in pleural fluid adds little to the diagnostic work-up of a pleural effusion and should not be used as an adjunct finding in determining malignancy.

    • © ERS Journals Ltd

    References

    1. ↵
      Dikmen G, Dikmen E, Kara M, Sahin E, Dogan P, Ozdemir N. Diagnostic implications of telomerase activity in pleural effusions. Eur Respir J 2003;22:422–426.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Giard RW, Hermans J. The diagnostic information of tests for the detection of cancer: the usefulness of the likelihood ratio concept. Eur J Cancer 1996;32A:2042–2048.
      OpenUrlPubMed
    3. ↵
      Jaeschke R, Guyatt GH, Sacket DL. Users' guides to the medical literature. III. How to use an article about diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994;271:703–707.
      OpenUrlCrossRefPubMedWeb of Science
    4. ↵
      McGee S. Simplifying likelihood ratios. J Gen Intern Med 2002;17:646–649.
      OpenUrlPubMedWeb of Science
    5. ↵
      Garcia-Pachon E. Tumor markers for diagnosing malignant pleural effusion?. Chest 2002;121:302.
      OpenUrlPubMed
    6. ↵
      Garcia-Pachon E, Llorca I. Diagnostic value of C‐reactive protein in exudative pleural effusions. Eur J Intern Med 2002;13:246–249.
      OpenUrlCrossRefPubMed
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 23 Issue 4 Table of Contents
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Diagnostic implications of telomerase activity in pleural effusions
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Diagnostic implications of telomerase activity in pleural effusions
    E. Garcia-Pachon, I. Padilla-Navas
    European Respiratory Journal Apr 2004, 23 (4) 653-654; DOI: 10.1183/09031936.04.00123204

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Diagnostic implications of telomerase activity in pleural effusions
    E. Garcia-Pachon, I. Padilla-Navas
    European Respiratory Journal Apr 2004, 23 (4) 653-654; DOI: 10.1183/09031936.04.00123204
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Clinical outcomes of bronchiectasis in India
    • Reply: Clinical outcomes of bronchiectasis in India
    • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society